Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients

Journal of Clinical Lipidology

Volumn 10, Issue 5, 2016, Pages 1163-1171

  Perez Martinez, Pablo ^a,b   Alcala Diaz, Juan F ^a,b   Kabagambe, Edmon K ^c   Garcia Rios, Antonio ^a,b   Tsai, Michael Y ^d   Delgado Lista, Javier ^a,b   Kolovou, Genovefa ^e   Straka, Robert J ^f   Gomez Delgado, Francisco ^a,b   Hopkins, Paul N ^g   Marin, Carmen ^a,b   Borecki, Ingrid ^h   Yubero Serrano, Elena M ^a,b   Hixson, James E ⁱ   Camargo, Antonio ^a,b   Province, Michael A ^h   Lopez Moreno, Javier ^a,b   Rodriguez Cantalejo, Fernando ^a   Tinahones, Francisco J ^b,j   Mikhailidis, Dimitri P ^k   Perez Jimenez, Francisco ^a,b   Arnett, Donna K ^l   Ordovas, Jose M ^m,n,o   Lopez Miranda, Jose ^a,b   more..

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e ONASSIS CARDIAC SURGERY CENTER   (Greece)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^k ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m TUFTS UNIVERSITY   (United States)

ⁿ CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^o IMDEA FOOD INSTITUTE   (Spain)

more..

Author keywords

CORDIOPREV study; Coronary heart disease; GOLDN study; Oral fat tolerance test; Postprandial lipemia; Triglycerides

Indexed keywords

TRIACYLGLYCEROL; FAT INTAKE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONTROLLED STUDY; DIET RESTRICTION; FAT TOLERANCE TEST; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGE; BLOOD; CORONARY ARTERY DISEASE; FAT INTAKE; HYPERLIPIDEMIAS; MIDDLE AGED; ODDS RATIO; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; CORONARY ARTERY DISEASE; DIETARY FATS; FEMALE; HUMANS; HYPERLIPIDEMIAS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POSTPRANDIAL PERIOD; PREVALENCE; TRIGLYCERIDES;

EID: 84977634630     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2016.05.009     Document Type: Article

References (35)

1. 1 Chapman, M.J., Ginsberg, H.N., Amarenco, P., et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 32:11 (2011), 1345–1361.
2. 2 Cohn, J.S., Postprandial lipemia and remnant lipoproteins. Clin Lab Med 26:4 (2006), 773–786.
3. 3 Schneeman, B.O., Kotite, L., Todd, K.M., Havel, R.J., Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A 90:5 (1993), 2069–2073.
4. 4 Nordestgaard, B.G., Varbo, A., Triglycerides and cardiovascular disease. Lancet 384:9943 (2014), 626–635.
5. 5 Langsted, A., Freiberg, J.J., Nordestgaard, B.G., Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118:20 (2008), 2047–2056.
6. 6 Kolovou, G., Ooi, T.C., Postprandial lipaemia and vascular disease. Curr Opin Cardiol 28:4 (2013), 446–451.
7. 7 Arca, M., Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome. Atheroscler Suppl 17 (2015), 12–16.
8. 8 Kolovou, G.D., Mikhailidis, D.P., Kovar, J., et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9:3 (2011), 258–270.
9. 9 Mihas, C., Kolovou, G.D., Mikhailidis, D.P., et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 9:3 (2011), 271–280.
10. 10 Lopez-Miranda, J., Williams, C., Lairon, D., Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98:3 (2007), 458–473.
11. 11 Alcala-Diaz, J.F., Delgado-Lista, J., Perez-Martinez, P., et al. Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study. PLoS One, 9(5), 2014, e96297.
12. 12 Wojczynski, M.K., Glasser, S.P., Oberman, A., et al. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. Lipids Health Dis, 10, 2011, 181.
13. 13 Delgado-Lista, J., Perez-Martinez, P., Garcia-Rios, A., et al. Coronary diet intervention with olive oil and cardiovascular prevention study (the CORDIOPREV study): Rationale, methods and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean dietrich in olive oil versus a low-fat diet on cardiovascular disease in coronarypatients. Am Heart J 177 (2016), 42–50.
14. 14 Perez-Martinez, P., Alcala-Diaz, J.F., Delgado-Lista, J., et al. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. Eur J Clin Invest 44:11 (2014), 1053–1064.
15. 15 Lai, C.Q., Arnett, D.K., Corella, D., et al. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arterioscler Thromb Vasc Biol 27:6 (2007), 1417–1425.
16. 16 Patsch, J.R., Miesenbock, G., Hopferwieser, T., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12:11 (1992), 1336–1345.
17. 17 Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
18. 18 Tsai, M.Y., Hanson, N.Q., Straka, R.J., et al. Effect of influenza vaccine on markers of inflammation and lipid profile. J Lab Clin Med 145:6 (2005), 323–327.
19. 19 Perez-Martinez, P., Corella, D., Shen, J., et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr 89:1 (2009), 391–399.
20. 20 Kabagambe, E.K., Ordovas, J.M., Tsai, M.Y., et al. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 203:2 (2009), 633–639.
21. 21 Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:16 (2009), 1640–1645.
22. 22 Nordestgaard, B.G., Benn, M., Schnohr, P., Tybjaerg-Hansen, A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:3 (2007), 299–308.
23. 23 Bansal, S., Buring, J.E., Rifai, N., Mora, S., Sacks, F.M., Ridker, P.M., Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298:3 (2007), 309–316.
24. 24 Boren, J., Matikainen, N., Adiels, M., Taskinen, M.R., Postprandial hypertriglyceridemia as a coronary risk factor. Clin Chim Acta 431 (2014), 131–142.
25. 25 Lopez-Miranda, J., Cruz, G., Gomez, P., et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 89:9 (2004), 4721–4728.
26. 26 Perez-Martinez, P., Lopez-Miranda, J., Ordovas, J.M., et al. Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus. J Mol Endocrinol 32:1 (2004), 237–245.
27. 27 Perez-Martinez, P., Delgado-Lista, J., Perez-Jimenez, F., Lopez-Miranda, J., Update on genetics of postprandial lipemia. Atheroscler Suppl 11:1 (2010), 39–43.
28. 28 Perez-Martinez, P., Ordovas, J.M., Garcia-Rios, A., et al. Consumption of diets with different type of fat influences triacylglycerols-rich lipoproteins particle number and size during the postprandial state. Nutr Metab Cardiovasc Dis 21:1 (2011), 39–45.
29. 29 Cohn, J.S., McNamara, J.R., Cohn, S.D., Ordovas, J.M., Schaefer, E.J., Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29:4 (1988), 469–479.
30. 30 Westerveld, H.E., Estrogens and postprandial lipid metabolism. Atherosclerosis 141:Suppl 1 (1998), S105–S107.
31. 31 Zaman, G.S., Rahman, S., Rahman, J., Postprandial lipemia in pre- and postmenopausal women. J Nat Sci Biol Med 3:1 (2012), 65–70.
32. 32 Chan, D.C., Pang, J., Romic, G., Watts, G.F., Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies. Curr Atheroscler Rep, 15(3), 2013, 309.
33. 33 Rached, F.H., Chapman, M.J., Kontush, A., An overview of the new frontiers in the treatment of atherogenic dyslipidemias. Clin Pharmacol Ther 96:1 (2014), 57–63.
34. 34 Humphries, S.E., Nicaud, V., Margalef, J., Tiret, L., Talmud, P.J., Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18:4 (1998), 526–534.
35. 35 Tiret, L., Gerdes, C., Murphy, M.J., et al. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest 30:7 (2000), 578–585.